Huaren Pharmaceutical Co., Ltd. (300110)
SZSE
Real-time Data
01:30 AM
Day's Range
2.7352 wk Range
2.41Overview - 300110 - Huaren Pharmaceutical Co., Ltd.
Key Statistics
Valuation
Enterprise Value
4.21B
P/E (Trailing)
‪25.08‬
P/E (Forward)
‪59.00‬
PEG Ratio
‪59.00‬
Price / Sales (TTM)
‪2.62‬
Price / Book
‪4.16‬
EV / EBITDA
‪18.73‬
Profitability
Gross Margin
‪33.24%‬
Profit Margin
‪-34.86%‬
Operating Margin
‪10.25%‬
Return on Assets
‪2.42%‬
Return on Equity
‪-39.64%‬
Ownership
Shares Outstanding
1.18B
Float
885.27M
Held by Insiders
‪39.46%‬
Held by Institutions
‪0.91%‬
Price stats
Beta
‪0.26‬
50-Day Avg
‪2.73‬
200-Day Avg
‪3.06‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Market Cap - 300110 - Huaren Pharmaceutical Co., Ltd.
Peers - 300110 - Huaren Pharmaceutical Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SZSE.
Profile Summary - 300110 - Huaren Pharmaceutical Co., Ltd.
About
Huaren Pharmaceutical Co., Ltd. is a diversified entity in the pharmaceutical industry dedicated to the research, development, production, and distribution of a wide array of medical products. The company focuses on creating medications that address chronic conditions and essential health needs, thereby significantly…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
